No products in the cart.
Dabrafenib plus trametinib provides clinically important response rates in BRAF-mutated gliomas
1. Response to treatment was noted in 33% of the high-grade glioma cohort and 69% of the low-grade cohort. 2. ...
Tag: glioma
Immunovirotherapy showed acceptable adverse-event profile in pediatric high-grade gliomas
1. Treatment with herpes simplex virus type 1 oncolytic virotherapy was shown not to demonstrate serious adverse events in pediatric ...
#VisualAbstract: Carboplatin holds potential as an adjunct therapy for recurrent high-grade glioma treatment
1. Carboplatin, given through intracerebral, convection-enhanced delivery, may be a viable adjunct in recurrent high-grade glioma treatment. Evidence Rating Level: 1 ...
Radiation plus chemotherapy confers survival benefit compared to radiation alone in low-grade gliomas
1. In grade 2 glioma patients younger than 40 years old that have undergone subtotal tumour resection, or in patients ...
Integrative genomic analysis promising for diagnostic subtyping of lower-grade glioma
1. Analysis of genomewide data revealed three robust, nonoverlapping, and clinically significant tumor classes based on presence of IDH mutation ...
Danish case control study links oral contraceptives with glioma
1. Hormonal contraception use was more prevalent among women who developed glioma, a brain tumor, to women without glioma. 2. ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.